Your browser doesn't support javascript.
loading
Central nervous system EBV lymphoproliferative disorder in a patient with rhabdomyosarcoma.
Nakashima, Kentaro; Kodama, Yuichi; Nishikawa, Takuro; Nishimura, Miho; Ito, Nobuhiro; Fukano, Reiji; Nomura, Yuko; Ueba, Tetsuya; Inoue, Tooru; Oshima, Koichi; Okamura, Jun; Inagaki, Jiro.
Afiliação
  • Nakashima K; Department of Pediatrics, National Kyushu Cancer Center, Fukuoka, Japan.
  • Kodama Y; Department of Pediatrics, National Kyushu Cancer Center, Fukuoka, Japan.
  • Nishikawa T; Department of Pediatrics, National Kyushu Cancer Center, Fukuoka, Japan.
  • Nishimura M; Department of Pediatrics, National Kyushu Cancer Center, Fukuoka, Japan.
  • Ito N; Department of Pediatrics, National Kyushu Cancer Center, Fukuoka, Japan.
  • Fukano R; Department of Pediatrics, National Kyushu Cancer Center, Fukuoka, Japan.
  • Nomura Y; Department of Pediatrics, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.
  • Ueba T; Department of Neurosurgery, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.
  • Inoue T; Department of Neurosurgery, Kochi Medical School, Kochi, Japan.
  • Oshima K; Department of Neurosurgery, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.
  • Okamura J; Department of Pathology, School of Medicine, Kurume University, Fukuoka, Japan.
  • Inagaki J; Department of Pediatrics, National Kyushu Cancer Center, Fukuoka, Japan.
Pediatr Int ; 58(5): 388-390, 2016 May.
Article em En | MEDLINE | ID: mdl-26738608
ABSTRACT
Epstein-Barr virus associated lymphoproliferative disorder (EBV-LPD) occurs in patients with immunodeficiency, but it has not been well described in patients who have received chemotherapy for solid tumors. We describe a child with rhabdomyosarcoma who developed isolated central nervous system (CNS) EBV-LPD during combination chemotherapy with vincristine, actinomycin D and cyclophosphamide. The patient was treated with high-dose methotrexate (HD-MTX) for CNS EBV-LPD and then treated with rituximab in addition to HD-MTX because of the emergence of LPD in the liver. I.v. rituximab combined with HD-MTX might be effective therapy for CNS EBV-LPD.
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Pediatr Int Assunto da revista: PEDIATRIA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Pediatr Int Assunto da revista: PEDIATRIA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Japão